BackgroundMany variants within the ABO gene across multiple subtypes have been identified. These variants are located in the coding region, the erythroid-specific regulatory element region of intron 1, splice sites, and other non-coding regions.
However, data regarding the functional analysis of these variants remain limited. In this study, we analyzed the function of two splice-site variants in ABO subtypes.MethodsABO phenotyping was performed using conventional serology methods.
The entire coding sequence of the ABO gene was characterized by polymerase chain reaction sequence-based typing, while haplotypes were determined using one-step long-range PCR combined with single-molecule real-time sequencing. The functional impact of splice-site variants was predicted using in silico tools and subsequently verified in vitro using a minigene splicing assay.
Furthermore, stable cell lines expressing ABO cDNA with exon 2 or 3 deletions were established to evaluate their effects on antigen expression utilizing serology, flow cytometry, and glycosyltransferase activity assays.ResultsThe c.98 + 3 heterozygous variants were identified in Bw and ABw individuals, while the c.155 + 1 heterozygous variant was identified in an ABw individual.
Frontiers in Immunology published a clinical update in Infectious Disease on 22 Apr 2026.
The item focuses on c.98 + 3A>G and c.155 + 1G>T splice-site variants in the ABO*B.01 allele lead to weak antigen expression in the Chinese individuals.
Review the original article for the full source wording and details.